ABL1 and non-small cell lung carcinoma: c‐Abl is overexpressed in NSCLC, and it has been reported that c‐Abl can be degraded through the ubiquitin–proteasome pathway (UPP) in the direction of ubiquitin ligase SMURF1,10 but its Dub remains elusive.